Skip to content

Clinical trials

Phase 3 Neoplasm Metastasis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Phase: Phase 3 Clear all

295 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20005
20018
200213
20039
200412
200512
200618
20078
20089
20099
20107
20119
201212
20138
201410
201512
201610
20177
20187
20199
20205
202118
202215
20238
20248
202516
202610

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed141
Terminated41
Recruiting35
Unknown status32
Active, not recruiting31
Not yet recruiting8
Withdrawn6
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca19
Alliance for Clinical Trials in Oncology10
Eli Lilly and Company10
Pfizer9
European Organisation for Research and Treatment of Cancer - EORTC8
Novartis Pharmaceuticals7
Sanofi7
Hoffmann-La Roche4
Radiation Therapy Oncology Group4
UNICANCER4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis295
Breast Neoplasms64
Colorectal Neoplasms44
Neoplasms42
Carcinoma, Non-Small-Cell Lung29
Prostatic Neoplasms25
Brain Neoplasms24
Melanoma18
Colonic Neoplasms16
Rectal Neoplasms13

Trials

Showing 51 to 75 of 295. Each trial links to its page on Pharma Observatory.

195 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.